Immuno-Oncology and Technology
Immuno-Oncology and Technology (IOTECH) is sister journal to Annals of Oncology and ESMO Open and the most recent addition to the European Society for Medical Oncology's portfolio of world-class journals. By publishing high quality original research articles, reviews, perspectives, technology explained papers, letters to the editor and editorials, IOTECH aspires to provide a forum for todays' leaders in the field of Immuno-Oncology.
Editor in Chief:
Professor John Haanen, Professor of Translational Immunotherapy of Cancer Leiden University Medical Center, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amersterdam, The Netherlands
Organizational Affiliations:
European Society for Medical Oncology (ESMO)
2024

Global Print Circulation
Online OnlyAvg. Global Monthly Visits
2,207Avg. Global Monthly Unique Visitors
1,004Avg. Global Monthly Page Views
1,210Avg. Global eTOC Distribution
24
eTOC Metrics: 12 Month Average of eTOC sends - July 2022 to June 2023
Monthly average web metrics based on the period of July 2022 to June 2023
Contacts
Display Advertising
-
Bill Hipple United States
646-671-0385
b.hipple@elsevier.com -
Kate Lach Europe
48 500 259 970
k.lach.1@elsevier.com -
Virginia Van Homrigh APAC
61 448 008159
v.vanhomrigh@elsevier.com -
Derek Zakaib Canada
514-730-8837
derekjohnzakaib@gmail.com
Recruitment Advertising
-
Jaesam Hong Global
212-633-3713
j.hong@elsevier.com
Have a question or need assistance?
Contact us now and a Sales Representative will be in touch.